Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
Cantor Fitzgerald
Federal Trade Commission
UBS
Boehringer Ingelheim
Citi
Colorcon
Fuji
Harvard Business School
Johnson and Johnson

Generated: February 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021345

« Back to Dashboard

NDA 021345 describes ARIXTRA, which is a drug marketed by Mylan Ireland Ltd and is included in one NDA. It is available from two suppliers. Additional details are available on the ARIXTRA profile page.

The generic ingredient in ARIXTRA is fondaparinux sodium. There are fourteen drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the fondaparinux sodium profile page.
Summary for 021345
Tradename:ARIXTRA
Applicant:Mylan Ireland Ltd
Ingredient:fondaparinux sodium
Patents:0
Therapeutic Class:Blood Products/Modifiers/ Volume Expanders
Formulation / Manufacturing:see details
Pharmacology for NDA: 021345
Mechanism of ActionFactor Xa Inhibitors
Suppliers and Packaging for NDA: 021345
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ARIXTRA fondaparinux sodium INJECTABLE;SUBCUTANEOUS 021345 NDA Physicians Total Care, Inc. 54868-5501 E 54868-5501-0
ARIXTRA fondaparinux sodium INJECTABLE;SUBCUTANEOUS 021345 NDA AUTHORIZED GENERIC Mylan Institutional LLC 67457-582 N 67457-582-10

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;SUBCUTANEOUSStrength2.5MG/0.5ML
Approval Date:Dec 7, 2001TE:APRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;SUBCUTANEOUSStrength5MG/0.4ML
Approval Date:May 28, 2004TE:APRLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;SUBCUTANEOUSStrength7.5MG/0.6ML
Approval Date:May 28, 2004TE:APRLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
QuintilesIMS
Express Scripts
Accenture
Colorcon
Mallinckrodt
Julphar
Healthtrust
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot